Navigation Links
Nuvilex Launches Video Marketing Campaign
Date:6/1/2009

CHERRY HILL, N.J., June 1 /PRNewswire-FirstCall/ -- Nuvilex, Inc. (OTC Bulletin Board: NVLX), an emerging healthcare consumer products company is now airing the first in a series of videos to promote the company and its products. Chairman and CEO Martin Schmieg leads off with an overview of the company's innovative and diverse product lines. This video is now running on the Nuvilex website at www.nuvilex.com and will be featured in corporate presentations and the Company's business development efforts.

Next up is a video commercial to promote Nuvilex' Last Shot Hangover Remedy. This new product eases hangover symptoms and is expected to launch Q3 2009 (July) in North America and Q4 2009 (October) worldwide. The Last Shot Hangover Remedy will air on various platforms including television, movie previews, and the Internet. Miller + Partners has been engaged to produce Nuvilex' video campaign.

About Miller + Partners

For over two decades, the consulting team at MILLER+PARTNERS has helped hundreds of top companies leverage the screen to communicate better, build brand awareness and heighten the users experience. Our Powermercial(TM) products enable our clients to reach across the social and sharing networks with engaging, entertaining and market focused video. For more information about Miller + Partners please visit us at www.GreatVideoSells.com.

About Nuvilex, Inc.

Nuvilex, formerly eFoodSafety.com, is an emerging healthcare consumer products company with a portfolio of aesthetics, dermatology, environmental and nutraceutical products. The company's focus is on developing, licensing and commercializing healthcare products that address the health needs of consumers worldwide. In March 2009, Nuvilex merged with Freedom2 Holdings, Inc., a diversified skin products technology company serving the fast-growing body art, aesthetic, cosmetic and skin therapy markets. More information is available at: http://www.nuvilex.com or www.freedom2inc.com.

Safe Harbor Statement

Statements contained in this presentation that are not strictly historical are "forward-looking" statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities and Exchange Act of 1934. The forward-looking statements are made based on information available as of the date hereof, and the Company assumes no obligation to update such forward-looking statements. Forward-looking statements are sometimes identified by words such as "intends", "anticipates", "believes", "expects", and "hopes" and involve a number of risks and uncertainties that could cause the Company's actual results to differ materially from projected results. All parties are cautioned that such forward-looking statements involve risks and uncertainties that could cause the Company's actual results to differ materially from those in these forward-looking statements. Such risks and uncertainties include but are not limited to demand for the Company's products and services, the planned share exchange with Freedom2 Holdings, Inc., our ability to secure additional financing, and other factors that may be more fully described in reports to shareholders and periodic filings with the Securities and Exchange Commission.

    Investor Relations Contacts:

    Blair Barnes
    Senior Vice President and Chief Financial Officer
    Nuvilex, Inc.
    Ph: 856-433-6088
    Email: bbarnes@nuvilex.com

    Stephanie Carrington/Amy Glynn
    The Ruth Group
    Ph: 646-536-7017/7023
    Email: scarrington@theruthgroup.com
    Email: aglynn@theruthgroup.com


    Press Contacts:

    Pat Arcand
    Arcand & Madison Public Relations
    Ph: 617-576-7777
    Email: pat@am-pr.com


'/>"/>
SOURCE Nuvilex, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Nuvilex Gets Update from CK41 on purEffect(TM) Launch Plan
2. Nuvilex Signs Agreement with Jayhur Enterprises to Distribute Infinitink - the Worlds First Permanent, But Easier to Remove Tattoo Ink - in Australia and New Zealand
3. Time Magazine Reports on Infinitink Tattoo Ink From Nuvilex
4. Nuvilex, Inc. Announces Monthly Investor Conference Call
5. Nuvilex Advances Release of Citroxin(TM) Antiviral Surface Cleaner to Help Combat Swine Flu
6. Nuvilex, Inc. Announces Investor Conference Call and Open House
7. Nuvilex, Inc.s Marketing Partner, CK41 to Launch purEffect(TM) in May
8. Nuvilex, Inc. Announces New Pricing for Cinnergen and Launch of dLife Advertising and Promotion Campaign
9. Nuvilex Provides Conference Call Replay Information
10. Nuvilex, Inc. Launches Spring Break Initiatives Designed to Raise Visibility Among Key Demographic Group
11. Nuvilex Infinitink Tattoo Ink Featured on PBS alt.news 26:46 TV Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2016)... ... 07, 2016 , ... The Cliff Hart Agencies, a Michigan-based ... Dewitt, Williamston, East Lansing, Ann Arbor, and Farmington Hills, is announcing a regional ... tumor. , Jason Bauer and his family are longtime members of the Williamston ...
(Date:12/7/2016)... ... 2016 , ... AlignLife clinics nationwide are giving back to their communities by ... receive bountiful gifts wrapped tightly under a Christmas Tree. AlignLife hopes to spread ... world. , In exchange for generous donations, customers will receive a gift in return. ...
(Date:12/7/2016)... ... 07, 2016 , ... The Honolulu cosmetic and medical dermatology ... launched October 17, 2016, features comprehensive information regarding a wide range of dermatologic ... patients can discover the latest clinical dermatology treatments for medical skin concerns as ...
(Date:12/7/2016)... ... December 07, 2016 , ... 1105 Media’s Live ... the Folio: Marketing Awards competition. Live From won in the Use of Social ... and ultimately successful projects undertaken by the media industry’s most innovative marketing professionals. ...
(Date:12/7/2016)... , ... December 07, 2016 ... ... announced its newest portable bioelectronic medicine device WellnessPro Plus for consumers and ... substantially enhances the WellnessPro platform by expanding the treatment modalities available in ...
Breaking Medicine News(10 mins):
(Date:12/6/2016)...  "Blood Tests replace Surgical Biopsies. Single screening ... Diagnostic, Monitoring and Screening Test opportunities are explored. ... using in vitro blood testing to identify cancer ... has announced a single blood test to detect ... the market. New technology that definitively identifies disease ...
(Date:12/6/2016)... 6, 2016 Anaplastic Oligoastrocytoma - Pipeline ... Direct,s latest Pharmaceutical and Healthcare disease pipeline guide ... an overview of the Anaplastic Oligoastrocytoma (Oncology) pipeline ... that forms when two types of cells in ... in number to form a mass. These brain ...
(Date:12/6/2016)... , Dec. 6, 2016 Eurofins ... accreditation from the College of American Pathologists (CAP) ... (CLIA) for its new laboratory in ... moved its North American headquarters. "Our ... sequencing -- which is still considered the ,Gold ...
Breaking Medicine Technology: